More than two years after its approval in Europe, PTC Therapeutics' gene therapy for rare genetic disorder AADC deficiency will soon be made available to patients in the US. The FDA has approved PTC's ...

In a potentially pivotal trial, PTC Therapeutics' experimental therapy for Huntington's disease (HD) met its primary endpoint, but questions about the data have raised doubts about the company's ...

PTC India Limited (PTC) is a provider of power trading solutions in India. The Company is engaged in investing in equity or extending debt to power projects in generation, transmission, distribution, ...

Financials PTC Inc's valuation ratios, including EV/EBITDA and P/E, have significantly decreased, suggesting the stock is becoming more attractive to investors. Growth metrics show strong revenue and ...

PTC Industries Limited is an India-based company, which is engaged in manufacturing of precision metal components for critical applications. It is primarily engaged in the manufacturing of metal ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

PTC Industries Ltd. is a Public Limited Listed company incorporated on 20/03/1963 and has its registered office in the State of Uttar Pradesh, India. Company's Corporate Identification Number(CIN) is ...

PTC India Ltd. is a Public Limited Listed company incorporated on 16/04/1999 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is ...

PTC India Ltd., incorporated in the year 1999, is a Small Cap company (having a market cap of Rs 5,608.17 Crore) operating in Power sector. PTC India Ltd. key Products/Revenue Segments include ...